Moreover, in high-risk and relapsed neuroblastoma, ST8SIA1 suppression by Yes-associated protein (YAP) has been implicated in resistance to GD2-targeted antibody therapies [67]. The gene discussed is ST8SIA1; the disease is neuroblastoma.